Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
96.515,65
-0,71%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Benitec Biopharma Limited (BNTC) Benitec Biopharma Limited (BNTC) Notizie

Benitec Biopharma Limited

BNTC
11,41
-0,76 (-6,24%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/12/202422:15EDGAR2Form 8-K - Current report
12/12/202400:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202423:00EDGAR2Form 8-K - Current report
06/12/202423:01EDGAR2Form 8-K - Current report
14/11/202422:37EDGAR2Form 8-K - Current report
14/11/202422:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/11/202422:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202422:31EDGAR2Form 8-K - Current report
13/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
01/11/202422:04EDGAR2Form S-3 - Registration statement under Securities Act of..
23/10/202415:23EDGAR2Form DEF 14A - Other definitive proxy statements
22/10/202423:24EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/10/202414:07EDGAR2Form 8-K - Current report
15/10/202412:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/10/202423:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/10/202422:53EDGAR2Form PRE 14A - Other preliminary proxy statements
11/10/202422:52EDGAR2Form 8-K - Current report
08/10/202422:45EDGAR2Form 8-K - Current report
01/10/202422:46EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/9/202422:43EDGAR2Form 8-K - Current report
26/9/202422:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/7/202422:28EDGAR2Form DEF 14A - Other definitive proxy statements
19/7/202422:59EDGAR2Form PRE 14A - Other preliminary proxy statements
15/7/202423:18EDGAR2Form 8-K - Current report
29/5/202422:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/5/202414:05EDGAR2Form 8-K - Current report
13/5/202414:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/3/202422:17EDGAR2Form 8-K - Current report
08/3/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:06EDGAR2Form DEL AM - Delaying amendment
23/2/202422:09EDGAR2Form S-3 - Registration statement under Securities Act of..
13/2/202414:15EDGAR2Form 8-K - Current report
13/2/202414:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 12,02 Min: 11,42 Max: 12,40
Chiusura: 12,17

La tua Cronologia

NASDAQ
BNTC
Benitec Biopharma
FX
CNYNZD
CNY vs NZD
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network